Boehringer Ingelheim Pharmaceuticals INC
At a glance
Employees20-99
In business sinceNot reported
HeadquartersRidgefield, CT
US patents280
SAM.gov UEIGH4RRVR2FHS7
CAGE code55391
Incorporated inDE
What they make
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
280 US patents granted 1986–2022, 1 of them in the five years to SEP 2025, including 4 design patents.
Pharmaceuticals 138Organic fine chemistry 114Measurement 12Biotechnology 5Chemical engineering 4
- Antibodies targeting a complex comprising non-classical HLA-I and neoantigen and their methods of useUS 11,359,023 · granted JUN 14, 2022
- Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereofUS 8,741,897 · granted JUN 3, 2014
- Pyrimidine derivativesUS 8,420,630 · granted APR 16, 2013
- Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereofUS 8,212,040 · granted JUL 3, 2012
- T cell proteins and nucleotides encoding the sameUS 8,168,752 · granted MAY 1, 2012
Newest 5 shown · Granted to Boehringer Ingelheim Pharmaceuticals, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plants
2 FACILITIES| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals INC | Ridgefield | CT | — | ACTIVE |
| Boehringer Ingelheim Pharmaceuticals - Columbus, OH | Columbus | OH | 20–99 | LIKELY ACTIVE |
WARN Act notices
- WARN notice effective JUL 3, 2017 · 28 employees · Boehringer Ingelheim Pharmaceuticals - Columbus, OH
- Plant closing notice effective FEB 1, 2017 · 119 employees · Boehringer Ingelheim Pharmaceuticals INC
Filed with the state under the federal WARN Act · WARN Act notices feed, CC BY 4.0
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.